Literature DB >> 19918118

Disrupted glutamate transporter expression in the spinal cord with acute flaccid paralysis caused by West Nile virus infection.

Pennelope K Blakely1, Bette K Kleinschmidt-DeMasters, Kenneth L Tyler, David N Irani.   

Abstract

Neuroinvasive West Nile virus (WNV) infections may cause acute flaccid paralysis (AFP); in fatal cases, anterior horn cell loss is presumed to be caused by direct viral infection. In related animal models, however, glutamate excitotoxicity mediates bystander injury of uninfected anterior horn cells, suggesting additional pathogenic mechanisms. We examined expression of the principal excitatory amino acid transporter (EAAT) of astrocytes (i.e. EAAT-2 in humans, glutamate transporter 1 in hamsters) in the spinal cord of human WNV-induced AFP patients and in hamsters with WNV-induced AFP by immunohistochemistry. Glial fibrillary acidic protein, synaptic and dendritic markers (i.e. synaptophysin, microtubule-associated protein 2), immune activation (HLA-DR), and viral antigens were also evaluated. Humans and hamsters with WNV-induced AFP had decreased spinal gray matter EAAT expression despite greater numbers of glial fibrillary acidic protein-positive astrocytes compared with controls. Areas of diminished EAAT expression showed reduced synaptic and dendritic protein expression and prominent local inflammation but few infected neurons. These findings suggest that WNV infection results in local immune activation within the spinal cord that in turn causes a failure of astrocyte glutamate reuptake even as the number of astrocytes increases; rising extracellular glutamate levels may then drive excitotoxic injury of both infected and uninfected anterior horn cells. The pathogenesis of this increasingly common disorder likely involves immune response and excitotoxicity mechanisms that are potential therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19918118      PMCID: PMC2854566          DOI: 10.1097/NEN.0b013e3181b8ba14

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  39 in total

1.  Recovery and prognosticators of paralysis in West Nile virus infection.

Authors:  Nancy Jingyang Cao; Chakpapani Ranganathan; William J Kupsky; Jun Li
Journal:  J Neurol Sci       Date:  2005-09-15       Impact factor: 3.181

2.  Sindbis virus-induced neuronal death is both necrotic and apoptotic and is ameliorated by N-methyl-D-aspartate receptor antagonists.

Authors:  J L Nargi-Aizenman; D E Griffin
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 3.  Neuroinflammation and regulation of glial glutamate uptake in neurological disorders.

Authors:  Sébastien Tilleux; Emmanuel Hermans
Journal:  J Neurosci Res       Date:  2007-08-01       Impact factor: 4.164

4.  Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.

Authors:  J D Rothstein; M Van Kammen; A I Levey; L J Martin; R W Kuncl
Journal:  Ann Neurol       Date:  1995-07       Impact factor: 10.422

5.  Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.

Authors:  J D Rothstein; M Dykes-Hoberg; C A Pardo; L A Bristol; L Jin; R W Kuncl; Y Kanai; M A Hediger; Y Wang; J P Schielke; D F Welty
Journal:  Neuron       Date:  1996-03       Impact factor: 17.173

6.  Evidence for synaptic stripping by cortical microglia.

Authors:  Bruce D Trapp; Jerome R Wujek; Gerson A Criste; Walid Jalabi; Xinghua Yin; Grahame J Kidd; Stephen Stohlman; Richard Ransohoff
Journal:  Glia       Date:  2007-03       Impact factor: 7.452

7.  Human T-cell lymphotropic virus type 1-infected T lymphocytes impair catabolism and uptake of glutamate by astrocytes via Tax-1 and tumor necrosis factor alpha.

Authors:  R Szymocha; H Akaoka; M Dutuit; C Malcus; M Didier-Bazes; M F Belin; P Giraudon
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120.

Authors:  Zhuying Wang; Olga Pekarskaya; Meryem Bencheikh; Wei Chao; Harris A Gelbard; Anuja Ghorpade; Jeffrey D Rothstein; David J Volsky
Journal:  Virology       Date:  2003-07-20       Impact factor: 3.616

9.  Clinical spectrum of muscle weakness in human West Nile virus infection.

Authors:  A Arturo Leis; Dobrivoje S Stokic; Risa M Webb; Sally A Slavinski; Jonathan Fratkin
Journal:  Muscle Nerve       Date:  2003-09       Impact factor: 3.217

10.  The inflammatory cytokine, interleukin-1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitis.

Authors:  Natalie A Prow; David N Irani
Journal:  J Neurochem       Date:  2008-01-14       Impact factor: 5.372

View more
  16 in total

1.  Glutamate excitotoxicity is involved in the induction of paralysis in mice after infection by a human coronavirus with a single point mutation in its spike protein.

Authors:  Elodie Brison; Hélène Jacomy; Marc Desforges; Pierre J Talbot
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  Activation of innate immune responses in the central nervous system during reovirus myelitis.

Authors:  Stephanie A Schittone; Kalen R Dionne; Kenneth L Tyler; Penny Clarke
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

3.  Gene Expression Profiling of Tuberculous Meningitis Co-infected with HIV.

Authors:  Ghantasala S Sameer Kumar; Abhilash K Venugopal; Manoj Kumar Kashyap; Rajesh Raju; Arivusudar Marimuthu; Shyam Mohan Palapetta; Yashwanth Subbanayya; Renu Goel; Ankit Chawla; Jyoti Bajpai Dikshit; Pramila Tata; H C Harsha; Jagadeesha Maharudraiah; Y L Ramachandra; Parthasarathy Satishchandra; T S Keshava Prasad; Akhilesh Pandey; Anita Mahadevan; S K Shankar
Journal:  J Proteomics Bioinform       Date:  2012-09-09

4.  Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis.

Authors:  Sivabalan Manivannan; Victoria K Baxter; Kimberly L W Schultz; Barbara S Slusher; Diane E Griffin
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

5.  Is initial preservation of deep tendon reflexes in West Nile Virus paralysis a good prognostic sign?

Authors:  Deb Kumar Mojumder; Melina Agosto; Henrik Wilms; Jongyeol Kim
Journal:  Neurol Asia       Date:  2014-03       Impact factor: 0.183

6.  West nile virus neuroinvasive disease.

Authors:  Roberta L Debiasi
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

7.  Death receptor-mediated apoptotic signaling is activated in the brain following infection with West Nile virus in the absence of a peripheral immune response.

Authors:  Penny Clarke; J Smith Leser; Eamon D Quick; Kalen R Dionne; J David Beckham; Kenneth L Tyler
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

8.  Novel treatment with neuroprotective and antiviral properties against a neuroinvasive human respiratory virus.

Authors:  Elodie Brison; Hélène Jacomy; Marc Desforges; Pierre J Talbot
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

Review 9.  SLC1 glutamate transporters.

Authors:  Christof Grewer; Armanda Gameiro; Thomas Rauen
Journal:  Pflugers Arch       Date:  2013-11-19       Impact factor: 3.657

10.  Neurological suppression of diaphragm electromyographs in hamsters infected with West Nile virus.

Authors:  John D Morrey; Venkatraman Siddharthan; Hong Wang; Jeffery O Hall; Neil E Motter; Robert D Skinner; Ramona T Skirpstunas
Journal:  J Neurovirol       Date:  2010-07       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.